Cargando…
OptiPharm: An evolutionary algorithm to compare shape similarity
Virtual Screening (VS) methods can drastically accelerate global drug discovery processes. Among the most widely used VS approaches, Shape Similarity Methods compare in detail the global shape of a query molecule against a large database of potential drug compounds. Even so, the databases are so eno...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361934/ https://www.ncbi.nlm.nih.gov/pubmed/30718737 http://dx.doi.org/10.1038/s41598-018-37908-6 |
_version_ | 1783392781780123648 |
---|---|
author | Puertas-Martín, S. Redondo, J. L. Ortigosa, P. M. Pérez-Sánchez, H. |
author_facet | Puertas-Martín, S. Redondo, J. L. Ortigosa, P. M. Pérez-Sánchez, H. |
author_sort | Puertas-Martín, S. |
collection | PubMed |
description | Virtual Screening (VS) methods can drastically accelerate global drug discovery processes. Among the most widely used VS approaches, Shape Similarity Methods compare in detail the global shape of a query molecule against a large database of potential drug compounds. Even so, the databases are so enormously large that, in order to save time, the current VS methods are not exhaustive, but they are mainly local optimizers that can easily be entrapped in local optima. It means that they discard promising compounds or yield erroneous signals. In this work, we propose the use of efficient global optimization techniques, as a way to increase the quality of the provided solutions. In particular, we introduce OptiPharm, which is a parameterizable metaheuristic that improves prediction accuracy and offers greater computational performance than WEGA, a Gaussian-based shape similarity method. OptiPharm includes mechanisms to balance between exploration and exploitation to quickly identify regions in the search space with high-quality solutions and avoid wasting time in non-promising areas. OptiPharm is available upon request via email. |
format | Online Article Text |
id | pubmed-6361934 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-63619342019-02-06 OptiPharm: An evolutionary algorithm to compare shape similarity Puertas-Martín, S. Redondo, J. L. Ortigosa, P. M. Pérez-Sánchez, H. Sci Rep Article Virtual Screening (VS) methods can drastically accelerate global drug discovery processes. Among the most widely used VS approaches, Shape Similarity Methods compare in detail the global shape of a query molecule against a large database of potential drug compounds. Even so, the databases are so enormously large that, in order to save time, the current VS methods are not exhaustive, but they are mainly local optimizers that can easily be entrapped in local optima. It means that they discard promising compounds or yield erroneous signals. In this work, we propose the use of efficient global optimization techniques, as a way to increase the quality of the provided solutions. In particular, we introduce OptiPharm, which is a parameterizable metaheuristic that improves prediction accuracy and offers greater computational performance than WEGA, a Gaussian-based shape similarity method. OptiPharm includes mechanisms to balance between exploration and exploitation to quickly identify regions in the search space with high-quality solutions and avoid wasting time in non-promising areas. OptiPharm is available upon request via email. Nature Publishing Group UK 2019-02-04 /pmc/articles/PMC6361934/ /pubmed/30718737 http://dx.doi.org/10.1038/s41598-018-37908-6 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Puertas-Martín, S. Redondo, J. L. Ortigosa, P. M. Pérez-Sánchez, H. OptiPharm: An evolutionary algorithm to compare shape similarity |
title | OptiPharm: An evolutionary algorithm to compare shape similarity |
title_full | OptiPharm: An evolutionary algorithm to compare shape similarity |
title_fullStr | OptiPharm: An evolutionary algorithm to compare shape similarity |
title_full_unstemmed | OptiPharm: An evolutionary algorithm to compare shape similarity |
title_short | OptiPharm: An evolutionary algorithm to compare shape similarity |
title_sort | optipharm: an evolutionary algorithm to compare shape similarity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361934/ https://www.ncbi.nlm.nih.gov/pubmed/30718737 http://dx.doi.org/10.1038/s41598-018-37908-6 |
work_keys_str_mv | AT puertasmartins optipharmanevolutionaryalgorithmtocompareshapesimilarity AT redondojl optipharmanevolutionaryalgorithmtocompareshapesimilarity AT ortigosapm optipharmanevolutionaryalgorithmtocompareshapesimilarity AT perezsanchezh optipharmanevolutionaryalgorithmtocompareshapesimilarity |